Kadmon’s Rezurock scores surprise FDA nod in chronic graft-versus-host-disease esagonowsky Fri, 07/16/2021 – 15:24 More: Kadmon's Rezurock scores surprise FDA nod in chronic graft-versus-host-disease Source: fierce
read moreBristol Myers Squibb’s Opdivo and Yervoy combo falls short in first-line squamous head and neck cancer kdunleavy Fri, 07/16/2021 – 11:38 More: Bristol Myers Squibb's Opdivo and Yervoy combo falls short in first-line squamous head and neck cancer Source: fierce
read moreAbbVie, Lilly atopic dermatitis hopefuls hit with more delays as FDA’s JAK inhibitor holdups carry on nhigginsdunn Fri, 07/16/2021 – 11:17 More: AbbVie, Lilly atopic dermatitis hopefuls hit with more delays as FDA's JAK inhibitor holdups carry on Source: fierce
read moreAlexion’s Ultomiris notches myasthenia gravis win amid quest for 3rd Soliris use fkansteiner Fri, 07/16/2021 – 09:29 More: Alexion's Ultomiris notches myasthenia gravis win amid quest for 3rd Soliris use Source: fierce
read moreBudget proposal to allow Medicare to negotiate prices should ‘enrage’ seniors, PhRMA says kdunleavy Fri, 07/16/2021 – 09:13 More: Budget proposal to allow Medicare to negotiate prices should 'enrage' seniors, PhRMA says Source: fierce
read moreDraft guidance recommends Ledaga for early-stage mycosis fungoides-type cutaneous T-cell lymphoma More: Ledaga recommended by NICE for rare type of lymphoma Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals